By using radiomics to reliably extract imaging features which are consistent with BRCA1/2 alterations, it may help improve selection of patients for genetic testing, which could subsequently expedite accurate diagnoses of BRCA alterations within this population, years prior to those alterations giving rise to breast and ovarian cancer diagnoses.14 This evidence concerns the gene BRCA1 and ovarian carcinoma.